225results about "Venous valves" patented technology

The invention discloses an integrated interventional venous valve and a preparation method thereof. The integrated interventional venous valve comprises a valve stent, a valve leaflet and a skirt; the valve stent comprises a first annular grid stent, a second annular grid stent and a straight rod for connecting the first annular grid stent and the second annular grid stent; the skirt edge covers the inner and outer surfaces of the first annular grid bracket and the second annular grid bracket; the valve leaflet is arranged on the straight rod, one side of the valve leaflet is connected with the skirt edge, and the free surface of the other side of the valve leaflet is arc-shaped; according to the integrated interventional venous valve, the valve leaflet and the skirt edge cover the inner surface and the outer surface of the valve support, so that the valve support, the valve leaflet and the skirt edge do not need to be fixed through sewing, the problems of complexity and potential tearing risk of split type processing are solved, and by arranging the material and the structure of the valve support, the integral interventional venous valve can be manufactured. And the valve leaflet free surface has a bionic arc shape, so that the integrated interventional vein valve can adapt to the diameter change of a blood vessel.

Single and dual frame prosthetic venous valve assemblies, and catheter delivery systems and methods, are disclosed. A representative dual frame venous valve assembly includes an outer valve frame having a lumen and a frame and venous valve assembly arranged within the lumen. The frame and venous valve assembly, which also may be a stand- alone prosthetic venous valve assembly, includes an inner valve frame having a frame matrix forming lateral valve supports and valve commissure supports; a polymeric frame coating encapsulating the frame matrix; and a one or more polymeric leaflets integrally formed with or coupled to the polymeric frame coating, with each leaflet moveable between an open or partially open state and a closed or partially closed state. A delivery catheter includes keys or slots for insertion of locking tabs of the outer valve frame, and a deployment control handle for controlling deployment of the venous valve assembly.

A nested valved pipeline comprises an outer pipeline, a pipeline support on the inner wall of the outer pipeline and valve leaflets arranged on the pipeline support, 3-5 main ribs extend from the center of the root of each valve leaflet to the edge of each valve leaflet, secondary branch ribs are distributed among the main ribs, and the main ribs and the secondary branch ribs form reinforcing ribs for net-shaped supporting; the reinforcing ribs are embedded into the valve leaflets and are integrally formed with the valve leaflets; the root of the reinforcing rib extends to the attachment area of the valve leaflet and the pipeline support to form a T-shaped anchoring structure, an annular groove is designed in the edge, close to the root of the valve leaflet, of the pipeline support, the T-shaped anchoring structure of the reinforcing rib is embedded into the groove of the pipeline support, and a gap between the valve leaflet and the pipeline support is filled with biological glue; the pipeline support and the outer pipeline are combined and fixed in a physical and chemical mode. The valve leaflet falling risk is reduced, the fatigue life is prolonged, and the reflux and thrombus risks are reduced; due to the nested design of the outer pipeline and the pipeline support, the connecting difficulty between the valve leaflet and the outer pipeline is reduced, and 3D complex design and batch production of the valve leaflet are conveniently achieved.

A system for regulating blood flow through a blood vessel of a heart includes a valve and a controller. The valve includes an outer frame and two or more leaflets and is sized for placement at least partially within the blood vessel. The two or more leaflets are sized to overlap or contact each other in an expanded state. The controller is disposed outside the heart and transmits signals to the valve.

Valvular implants and blood vessel closure devices herein are configured to be positioned in the heart and to block regurgitant blood flow from the heart into blood vessels supplying blood to the heart. The valvular implants can have a cover, a membrane, a valve, a resilient frame, and / or other features. Some valvular implants can have anchors to be positioned in the blood vessels, such as in pulmonary veins, and can anchor the implant to the heart wall. Various embodiments of covers and / or membranes act as valves contracting and expanding, to alternately permit and block blood flow. The valvular implants can cover one or more blood vessels, such as one, two, three, or four pulmonary veins, and can also be configured and implanted to block an appendage to the heart, such as the left atrial appendage.

A stent including a tubular body formed of one or more interwoven wires, a first anchor member disposed adjacent the first open end of the stent, a second anchor member disposed adjacent the second open end of the stent, and at least one divider disposed between the first and second anchor members. The first and second anchor members and the divider extend radially outward from the tubular body to divide the tubular body into at least a first saddle region extending between the first anchor member and the divider and a second saddle region extending between the second anchor member and the divider.

The present disclosure relates to a method and a device for treating heart failure by normalizing elevated blood pressure in the left and right atria of a heart of a mammal. The present disclosure includes methods for creating and maintaining an opening in the atrial septum. Tools for making an opening and enlarging the opening are also disclosed. Use of the techniques and tools described herein prolongs the patency of an intra-atrial pressure relief opening.

Single and dual frame prosthetic venous valve assemblies, and catheter delivery systems and methods, are disclosed. A representative dual frame venous valve assembly includes an outer valve frame having a lumen and a frame and venous valve assembly arranged within the lumen. The frame and venous valve assembly, which also may be a stand-alone prosthetic venous valve assembly, includes an inner valve frame having a frame matrix forming lateral valve supports and valve commissure supports; a polymeric frame coating encapsulating the frame matrix; and a one or more polymeric leaflets integrally formed with or coupled to the polymeric frame coating, with each leaflet moveable between an open or partially open state and a closed or partially closed state. A delivery catheter includes keys or slots for insertion of locking tabs of the outer valve frame, and a deployment control handle for controlling deployment of the venous valve assembly.

An implantable prosthetic valve includes a radially collapsible and expandable annular frame having three commissure attachment posts and four rows of circumferential struts. The rows include a first row, a second row downstream of the first row, a third row downstream of the second row, and a fourth row downstream of the third row and defining an outflow end of the frame. Each row of circumferential struts includes angled struts arranged in a zig-zag pattern. A leaflet structure includes three leaflets forming three commissures, each commissure being connected to one of the commissure attachment posts only at locations along the commissure attachment posts between a first plane that is perpendicular to a longitudinal axis of the frame and intersects crowns of the third row of struts and a second plane that is perpendicular to the longitudinal axis and intersects crowns of the fourth row of struts.

A device may include a control element coupled to a valve disposed in an outer frame. The control element is configured to manipulate the valve between an unrestricted blood flow state and a restricted blood flow state. A device may include an actuation device including a linear actuator coupled to a control element of an implantable device, and a first magnet configured to induce rotation of the linear actuator. A control device communicatively coupled to the linear actuator includes a second magnet configured to generate a changing magnetic field pole direction to cause rotation of the first magnet either to tension the control element to position a valve of the implantable device in a restricted blood flow state or to release tension in the control element to position the valve in an unrestricted blood flow state.

A cardiac implant device may include a frame sized for placement at least partially within a blood vessel of a heart, the frame having a proximal end, a distal end, and a midsection, and comprising an outer frame and an inner frame. At least a portion of the inner frame is joined to the outer frame at the distal end of the frame and wherein the inner frame extends away from the outer frame at the midsection of the frame to form a gap between the inner frame and the outer frame. A device may include a sealing skirt extending at least partially along the inner frame and the distal end of the frame.

A delivery system for a blood flow occluder system is provided that includes a handle. The handle includes a distal portion, a proximal portion, an actuator, and a carriage. The actuator is positioned between the proximal portion and the distal portion. The actuator is moveable (e.g., rotatable) relative to an external surface of the handle. The carriage is disposed in the handle. The actuator is configured to cause movement of the carriage to deploy the blood flow occluder system.

A flow restrictor for a blood vessel can include a frame positionable within a blood vessel, an inner cell, a leaflet, and a lumen through the flow restrictor. The lumen is defined at least in part by the leaflet. An inflow edge of the leaflet can be coupled to a movable junction of the inner cell, and an outflow edge of the leaflet can be coupled to an anchoring junction of the inner cell. The movable junction of the inner cell and the inflow edge of the leaflet can be configured to move axially in response to a first increase in a blood pressure within the blood vessel, and in response to the blood pressure within the blood vessel being within a first blood pressure range. The movable junction and the leaflet can be configured such that the lumen changes size when the movable junction moves.

A medical implant for managing blood flow through a blood vessel comprises a plug, a mounting ring, and one or more arms interconnecting the plug and the mounting ring, wherein the one or more arms are configured to allow movement of the plug relative to the mounting ring.

To provide transcatheter implantable device frames, and docking stations or docking devices for transcatheter implantable devices.SOLUTION: Docking stations for transcatheter valves are described. The docking stations can include an expandable frame, at least one sealing portion, and a valve seat. The expandable frame can be configured to conform to an interior shape of a portion of the circulatory system when expanded inside the circulatory system. The sealing portion can be configured to contact an interior surface of the circulatory system to create a seal. The valve seat can be connected to the expandable frame and can be configured to support an expandable transcatheter valve. The docking stations are adaptable to different anatomies / locations to allow implantation of a transcatheter valve in a variety of anatomies / locations.SELECTED DRAWING: Figure 6

A fixation device includes a central assembly and an arm moveably coupled to the central assembly. The arm includes a body portion having a first end and a second end. The second end is moveable between a closed position and an open position. The body portion also includes opposing body lateral sides each extending between the first end and the second end and a body portion width defined between the opposing body lateral sides. The arm further includes first and second nondeformable wing extensions each extending laterally from a respective lateral side and having a lateral outer edge. A maximum arm width of the arm is defined between the outer lateral edge of the first wing extension and the outer lateral edge of the second wing extension. The fixation device further includes a gripping element moveable relative to the arm to capture a native leaflet therebetween.

Systems and methods for regulating fluid flow are provided. A valve for regulating fluid flow includes a tubing, a regulating element, and an actuator. The tubing is configured to allow fluid flow therethrough. The regulating element is arranged proximate to the tubing. The actuator is arranged proximate to the regulating element, and is configured to manipulate a parameter associated with the regulating element.

The present disclosure is directed to embodiments of catheter-based prosthetic heart valves. In one embodiment, a prosthetic heart valve includes a collapsible and expandable annular frame, a leaflet assembly mounted within the annular frame, a first skirt mounted on the frame, and a second skirt mounted on the frame. The frame includes a plurality of rows of cells. The leaflet assembly includes a plurality of leaflets. Adjacent leaflets are connected to each other to form commissures, each of which is connected to a cell of an outflow row of cells of the frame.

A system for regulating blood flow through a blood vessel of a heart, the system comprising a valve comprising an outer frame and configured for placement at least partially within the blood vessel.

A cardiac implant device comprises a frame configured for placement at least partially within a blood vessel of a heart, a skirt configured to at least partially enclose the frame, and two or more arms extending from a distal end of the frame.

Various systems, devices, components, and methods for controllably and selectively occluding, limiting, and / or diverting flow within a patient's vasculature are disclosed. The flow restriction system may include an implant having a flow restrictor and an implantable controller having an actuator for actuating the flow restrictor. The flow limiting system may also include an external device for controlling operation of the implant via the implantable controller.

This invention relates to a valve prosthesis and a stent, the stent comprising a first stent. The first stent includes two first rod groups, and a first axial rod and a second axial rod connecting the two first rod groups and arranged along the axial direction of the stent. Each first rod group includes a plurality of first rods connected end-to-end and arranged in a W-shape. The first crests of the two first rod groups are arranged opposite each other, and the first troughs are arranged opposite each other. At least one or more of the two oppositely arranged first crests are connected by one or more first axial rods, and the two oppositely arranged first troughs are connected by one or more second axial rods. In this way, the arrangement density of the axial rods can be increased, thereby improving the radial support strength, so that it can be stably fixed at the location of the original valve; in addition, the enclosed quadrilateral structure can be easily bent under stress, that is, it will not affect the normal storage and folding of the stent.

A medical implant for managing blood flow through a blood vessel comprises a stent body forming a proximal portion and a tapered distal end, the tapered distal end being angled relative to the proximal portion to face a direction of blood flow and limit blood flow into an inner lumen of the stent body, and the tapered distal end having a flexible structure to allow the tapered distal end to bend and straighten in response to blood flow, and a covering extending along the stent body.

A method and a system for performing a medical procedure including a scaffold for implanting in a hollow structure of a mammalian patient. The system includes a delivery device configured to deliver the scaffold to an implant location within the hollow structure. The scaffold, or one or more portions of scaffold, can be configured to bioabsorb, biodegrade, and / or otherwise decompose after implantation in a patient. The bioabsorption can occur over a period of time, such as a predetermined time period.

The present invention discloses an artificial coronary sinus valve for treating myocardial ischemia, comprising: an external support, a spiral elastic sheet valve. The external support comprises a first fixing member and a second fixing member arranged along its center line and a plurality of struts distributed around the center line of the external support, wherein the strut comprises a plurality of sections connected in sequence from the first end to the second end, and any two adjacent sections are connected in a smooth transition; the spiral elastic sheet valve is a one-way flow guide attached to the inside of the external support, which has pressure compliance, and when the liquid flows from the first fixing member of the external support to the second fixing member and the liquid pressure is lower than the preset pressure value or when the liquid flows from the second fixing member of the external support to the first fixing member, the one-way flow guide is closed. The structural design of the artificial valve can effectively improve the perfusion and cardiac function of the myocardial tissue and solve the problem that the artificial valve is difficult to match the human anatomical structure.

This application generally relates to an transcatheter anti-reflux venous valve endoprosthesis system, including a replacement valve, a valve support frame, crimping system, and delivery system to treat patients with chronic venous insufficiency, and method for using such a system.

An implantable medical device for preventing backflow into a false lumen of dissection includes an elongate support member, an elongate flexible tubular valve member having a length, a proximal end, and an open distal end. At least one elongate resilient member extends at least partially along the length of the elongate flexible tubular valve member, the at least one elongate resilient member having a proximal end distal to the elongate support member, a distal end proximal to the open distal end of the elongate flexible tubular valve member, an elongated configuration, and a coiled configuration. The at least one elongate resilient member is unattached to the elongate support member. The at least one elongate resilient member, upon release from a constraining force, is configured to move from the elongated configuration to the coiled configuration thereby closing the open distal end of the elongate flexible tubular valve member.

Various systems, devices, components and methods are disclosed for controllably and selectively occluding, restricting, and / or diverting flow within a patient's vasculature. The flow restriction systems can include an implant having a flow restrictor and an implantable controller having an actuator for actuating the flow restrictor. The flow restriction systems can also include an external device for controlling operation of the implant via the implantable controller.

The present disclosure relates to a method and a device for treating heart failure by normalizing elevated blood pressure in the left and right atria of a heart of a mammal. The present disclosure includes methods for creating and maintaining an opening in the atrial septum. Tools for making an opening and enlarging the opening are also disclosed. Use of the techniques and tools described herein prolongs the patency of an intra-atrial pressure relief opening.

A flow restrictor for a blood vessel can include a frame positionable within a blood vessel, an inner cell, a leaflet, and a lumen through the flow restrictor. The lumen is defined at least in part by the leaflet. An inflow edge of the leaflet can be coupled to a movable junction of the inner cell, and an outflow edge of the leaflet can be coupled to an anchoring junction of the inner cell. The movable junction of the inner cell and the inflow edge of the leaflet can be configured to move axially in response to a first increase in a blood pressure within the blood vessel, and in response to the blood pressure within the blood vessel being within a first blood pressure range. The movable junction and the leaflet can be configured such that the lumen changes size when the movable junction moves.